Hysteroscopy

Meditrina Announces CE Mark Approval and First Multi-International Cases Performed

Retrieved on: 
Martedì, Maggio 14, 2024
Health care, UKCA, Diagnosis, Safety, Hysteroscopy, Health, SAN, Uterus, Senior, Regulation, Growth, Woman, Aveta, CE marking, European, Medical device

SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy System.

Key Points: 
  • SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy System.
  • Receiving the UKCA and CE Mark approval underscores Meditrina's dedication to meeting the highest standards of quality, safety, and efficacy required for market entry in the European Union and the UK.
  • This achievement not only validates the company's commitment to regulatory compliance but also positions Meditrina as a trusted provider of cutting-edge medical solutions.
  • "We are excited to receive UKCA and CE Mark approval for our hysteroscopy system, as it validates the exceptional quality and performance of our product," remarked Csaba Truckai, CEO of Meditrina.

Meditrina Welcomes Senior Vice President of Global Sales to Lead Expansion Efforts and Manage Rapid Growth

Retrieved on: 
Martedì, Maggio 14, 2024
Hologic, Health, SAN, Senior, Regulation, Growth, GYN, Culture, Woman, Hysteroscopy, CE marking, Management

SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- Meditrina, a leader in gynecologic medical devices, announced today the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.

Key Points: 
  • SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- Meditrina, a leader in gynecologic medical devices, announced today the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.
  • In his new role, Ray will leverage his extensive industry experience to accelerate Meditrina's sales initiatives on a global scale.
  • Ray expressed his enthusiasm about joining Meditrina, stating, "I am thrilled to be joining Meditrina as the Senior Vice President of Global Sales.
  • With Ray at the helm of global sales operations, Meditrina is primed to seize emerging market opportunities and cement its reputation as a trailblazer in hysteroscopy innovation.

FzioMed, Inc. to Showcase its Women's Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress

Retrieved on: 
Martedì, Aprile 16, 2024
Adhesion, Curettage, Pain, Ovary, Congress, Refrigeration, Safety, Pregnancy, Risk, Tissue, Infertility, Federico, Marketing, Doctor of Philosophy, Obstetrics, Gynaecology, Hysteroscopy, Teaching hospital, Patient satisfaction, SAN, Medical director, The Company, Gel

The Company will showcase its innovative Oxiplex® adhesion barrier gel product portfolio designed to reduce the formation of post-surgical adhesions following hysteroscopic and laparoscopic surgery.

Key Points: 
  • The Company will showcase its innovative Oxiplex® adhesion barrier gel product portfolio designed to reduce the formation of post-surgical adhesions following hysteroscopic and laparoscopic surgery.
  • Based on a patented formulation and more than 20 years of use, these barrier products provide a temporary, mechanical separation of tissues during the normal healing process, reducing adhesion formation.
  • "Formulated specifically for intrauterine procedures, our Oxiplex/IU Adhesion Barrier Gel works in concert with the natural healing process to reduce adhesion formation.
  • The Oxiplex portfolio of adhesion barrier products has been available since 2002 and have been used in nearly 1 million procedures worldwide.

Mercy's Susan T. Peeler, M.D., and Patricia McMullen, WHNP, named Winners of inaugural Interprofessional Humanism in Healthcare Award

Retrieved on: 
Giovedì, Gennaio 4, 2024
Woman, Health, Catholic higher education, BSN, Humanism, Collaboration, The Institute, MBA, Dean, University, Practitioner, FAAN, Family, DRS, Physician, JD, Catholic University of America, WHNP-BC, Hysteroscopy, Maryland School, WHNP, CNS, Patient, Mercy Hospital, Colposcopy, Gold, Partnership, GYN, AACN, Doctor of Philosophy, MD, FACOG, RN, Organization, Nursing

BALTIMORE, Jan. 4, 2024 /PRNewswire-PRWeb/ -- The Arnold P. Gold Foundation and the American Association of Colleges of Nursing (AACN) have announced the winners of the inaugural AACN-Gold Interprofessional Humanism in Healthcare Award, a new honor that celebrates and elevates the collaboration of physicians and nurses.Susan Todd Peeler, M.D., FACOG, MBA, and Patricia McMullen, PhD, JD, CNS, WHNP-BC, were recognized in December 2023 for their partnership in supporting comprehensive women's healthcare and disseminating best practices on women's health to clinicians across a wide range of disciplines.

Key Points: 
  • Mercy's Susan T. Peeler, M.D., and Patricia McMullen, WHNP, have been named recipients of the inaugural AACN-Gold Interprofessional Humanism in Healthcare Award, a new honor that celebrates and elevates the collaboration of physicians and nurses.
  • The Institute provides routine women's healthcare, as well as services for complex gynecological issues for women of all ages.
  • The new award will be centered each year on a theme, which this year is "Innovations in Interprofessional Collaboration that Drive Humanism in Healthcare."
  • Peeler and McMullen will be presented with the AACN-Gold Interprofessional Humanism in Healthcare Award at the 2024 Gold Humanism Summit in Atlanta, Georgia.

Hologic Announces Innovative Collaboration with AAGL and Inovus Medical to Optimize OB-GYN Training for Minimally Invasive Surgeries

Retrieved on: 
Martedì, Ottobre 10, 2023
Surgery, Women, Consumer, Health, Health Technology, Linda, Omni, Uterine fibroid, Partnership, Accreditation Council for Graduate Medical Education, HOLX, Hysteroscopy, American Board of Obstetrics and Gynecology, Accreditation, AAGL, Graduate medical education, AUB, American Board of Commissioners for Foreign Missions, Patient, Entrepreneurship, Hologic, Gynaecology, Obstetrics, Woman, Life, Birth control, Nursing

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.

Key Points: 
  • Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.
  • Hologic becomes the chief provider of hysteroscopes for AAGL’s Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.
  • AAGL contracts with Inovus Medical, an award-winning designer and manufacturer of surgical training technologies, for the manufacturing and delivery of the hands-on training equipment for EMIGS.
  • “Our collaboration with Hologic and Inovus provides the vital infrastructure needed to bring EMIGS to life,” said Linda Michels, AAGL Executive Director.

World Laparoscopy Hospital - Recognized as the Most Popular Institute for Laparoscopic Surgery by the World Association of Laparoscopic Surgeons

Retrieved on: 
Venerdì, Aprile 28, 2023
WALS, Knowledge, Hospital, Bariatric surgery, World Association of Eye Hospitals, Surgeon, Research, Patient, Education, Hysteroscopy, Dentistry, Nursing

NEW DELHI, April 28, 2023 /PRNewswire/ -- World Laparoscopy Hospital has been recognized as the most popular institute for laparoscopic surgery by the World Association of Laparoscopic Surgeons (WALS).

Key Points: 
  • NEW DELHI, April 28, 2023 /PRNewswire/ -- World Laparoscopy Hospital has been recognized as the most popular institute for laparoscopic surgery by the World Association of Laparoscopic Surgeons (WALS).
  • World Laparoscopy Hospital is renowned for its cutting-edge training programs, which cover a wide range of minimally invasive surgical techniques, including laparoscopic surgery, robotic surgery, and hysteroscopy.
  • Their state-of-the-art facilities and experienced team of surgeons have attracted medical professionals from across the globe, making World Laparoscopy Hospital the go-to destination for high-quality laparoscopic surgery training .
  • In addition to laparoscopic surgery, World Laparoscopy Hospital offers a range of training programs in robotic surgery , hysteroscopy, bariatric surgery, and other related fields.

A New Device Reduces Uterine Bleeding Suffered by One in Three Women of Reproductive Age

Retrieved on: 
Venerdì, Aprile 28, 2023
Depression, Bleeding, Obstetrics, Hospital, Absenteeism, Quality of life, Woman, Cramp, Gynaecology, Abdominal pain, Uterus, La Mega Media, Pain, Congress, Cyclic permutation, SEAD, Canadian International Council, Risk, Anemia, Sport, International Journal of Gynecology & Obstetrics, Patient, Health, Birth control, Hysteroscopy

SITGES, Spain, April 28, 2023 /PRNewswire/ -- A new device has been presented at the 4th World Congress of Hysteroscopy in Sitges (Barcelona), which brings together 1,000 women's health specialists, allows for the reduction of abnormal uterine bleeding that affects one in three women of reproductive age and limits their quality of life.

Key Points: 
  • "Abnormal uterine bleeding is one of the main reasons for consultation in gynecology.
  • In this regard, a study published in the International Journal of Gynecology and Obstetrics found that women who experienced abnormal uterine bleeding had more days of work absenteeism than those who did not.
  • Other studies have shown that 4 out of 10 women suffer from depression as a result of these periods.
  • This minimally invasive procedure uses a spherical device to remove the lining of the uterus and reduce the amount of menstrual bleeding.

Accure Acne, Inc. Continues to Strengthen Leadership Team with Addition of Industry Veteran Alfred Intintoli

Retrieved on: 
Mercoledì, Aprile 12, 2023
Singer Corporation, Intellectual property, University, SPIE, Arthroscopy, Laboratory for Laser Energetics, CE marking, Clinical trial, Acne, Research, Hysteroscopy, Light, Neurosurgery, Patent, IRB, Optics, Engineering, Entrepreneurship, FDA, Professional corporation, Laboratory, Society, International Society, Medical imaging, Isotretinoin

BOULDER, Colo., April 12, 2023 /PRNewswire/ -- Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that Alfred (Al) Intintoli has joined the company as Chief Technology Officer. Mr. Intintoli has over forty years of professional experience in laser, optical and medical device development. He has a unique combination of research & development, engineering, operations, regulatory, quality, clinical trial oversight, intellectual property and product commercialization experience that is well suited as Accure transitions into a world-class commercial organization. Mr. Intintoli spent the past eight years leading a team at Trice Medical from an early-stage start-up through to commercialization. During this time, Mr. Intintoli grew their medical device offerings, and incorporated products from three acquisitions into the quality and regulatory systems as well as expanded upon their original product offerings. Prior to that experience, Mr. Intintoli held ever-increasing roles in research & development, engineering, clinical trial oversight, and operations at PhotoMedex, Surgical Laser Technologies, Quantronix Corporation, the Kearfott Division of the Singer Company, and the Laboratory of Laser Energetics. Mr. Intintoli has a B.S. degree in optical engineering (with distinction) from the University of Rochester, Institute of Optics.  Mr. Intintoli is a member of the American Society for Laser Medicine and Surgery (ASLMS) and the International Society for Optics and Photonics (SPIE), and holds numerous patents in the fields of neurosurgery, hysteroscopy, arthroscopy, hair regrowth suppression, ultraviolet phototherapy, tissue visualization and laser delivery.

Key Points: 
  • The addition of Alfred "Al" Intintoli strengthens the capabilities of Accure Acne, this innovative company that is the first with both FDA and CE Mark clearances for a 1726nm laser for the treatment of mild-to-severe inflammatory acne vulgaris.
  • Mr. Intintoli has over forty years of professional experience in laser, optical and medical device development.
  • Mr. Intintoli spent the past eight years leading a team at Trice Medical from an early-stage start-up through to commercialization.
  • "Mr. Intintoli succeeds Henrik Hofvander, who led our technological development and remains with Accure as Chief Technology Officer- Emeritus.

INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute

Retrieved on: 
Lunedì, Marzo 20, 2023
San Francisco, IVC, Madison, University, Bank statement, Calendar, Fertility clinic, Fertilisation, Reproduction, IVF, Yale School of Medicine, Gynaecology, Acquisition, Fertility, Growth, Innovation, Birth control, Infertility, Hysteroscopy

SARASOTA, Fla. and MADISON, Wis., March 20, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced it has signed binding agreements to acquire Wisconsin Fertility Institute. The Madison-based fertility center primarily offers conventional IVF procedures and generated approximately $5.5 million in revenue and net income of approximately $1.9 million for the trailing 12-month period ended September 30, 2022. 

Key Points: 
  • The Wisconsin Fertility Institute immediately adds scale and positive cash flow to our operations and we expect to drive incremental growth at the clinic with the synergistic introduction of our INVOcell solution."
  • Wisconsin Fertility Institute is one of the state's preeminent fertility centers, having helped to welcome over 5,000 babies since opening its doors in 2007 and with approximately 550 conventional IVF procedures completed in 2022.
  • Wisconsin Fertility Institute joins INVO's expanding list of fertility clinics, including operating clinics in Atlanta (Bloom Fertility), Birmingham (Innovative Fertility Specialists) and Monterrey, Mexico (Positib Fertility), as well as future clinics under development, such as the wholly owned INVO Center in Tampa, Florida that is currently under construction.
  • Upon closing of the transaction, Wisconsin Fertility Institute will become a wholly owned subsidiary, and its financial statements will be consolidated with those, of INVO.

Biopsy Devices Market Predicted to Achieve Striking Growth of USD 3.96 Billion with Healthy CAGR of 7.3% by 2029, Size, Share, Trends, Demand and Competitive Analysis

Retrieved on: 
Martedì, Marzo 7, 2023
Sentinel, Laparoscopy, Diagnosis, Needle, Laboratory, DNA, Lymph node, Infection, Liquid biopsy, Breast cancer, Jamshidi needle, Nucleic acid thermodynamics, Saliva, Skin cancer, Magnetic resonance, Ambulatory Surgery Center Association, EVS, Archives of Pathology & Laboratory Medicine, Consumables, Prostate, Research, Disposable product, Midsayap Diagnostic Center and Hospital, Cancer, Academic institution, Prostate cancer, Prostate biopsy, Recurrence, Neoplasm, System, Lung cancer, National Virus Reference Laboratory, MRI, Inflammation, Liver cancer, Wilford Hall Ambulatory Surgical Center, Skeletal muscle, Biomarker, Seminal vesicles, Fine-needle aspiration, Chinese, Stereotactic surgery, Medical imaging, Trans, Hospital, Biopsy, Hysterectomy, Disease, Human factors and ergonomics, Country, Hysteroscopy

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...

Key Points: 
  • To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...
    North America Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-biopsy-de...
    Europe Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Mri-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country https://www.databridgemarketresearch.com/reports/europe-biopsy-devices-m...
    Asia-Pacific Biopsy Devices Market By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/asia-pacific-biopsy-dev...
    Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) https://www.databridgemarketresearch.com/reports/global-breast-biopsy-de...
    North America Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems and Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization and Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy and Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Other), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-breast-bi...
    Europe Breast Biopsy Devices Market , By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), Type (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy, Other Biomarkers), Guidance (Image-Guided Biopsy, Liquid Biopsy, Other Guidance Techniques), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), Country https://www.databridgemarketresearch.com/reports/europe-breast-biopsy-de...
    Asia-Pacific Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other), Country https://www.databridgemarketresearch.com/reports/asia-pacific-breast-bio...
    Smart Biopsy Devices Market , By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers) Country https://www.databridgemarketresearch.com/reports/global-smart-biopsy-dev...
    Vacuum Assisted Biopsy Devices Market , By Product (Vacuum-assisted Biopsy Systems, Vacuum-assisted Biopsy Needles), Type (9-12G, 12G), Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, Others), Applications (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others) https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Endobronchial Ultrasound Biopsy Devices Market , By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Trans bronchial Aspiration Needles, Spray Catheters, Others), Application (Cancer Diagnosis, Infection Diagnosis, Others), Country https://www.databridgemarketresearch.com/reports/global-endobronchial-ul...
    Liquid Biopsy Market , By Sampling Type (Blood Sampling Liquid Biopsy, Urine Sampling Liquid Biopsy and Saliva and Other Tissue Fluids Sampling Liquid Biopsy), Products and Service (Assays Kits, Instruments and Services), Circulating Biomarker (Circulating Tumour Cells, Circulating Tumour DNA (CTDNA), Cell-Free DNA, Extracellular Vesicles (EVS) and Other Circulating Biomarkers), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring and Recurrence Monitoring), Application (Cancer Applications and Non-Cancer Applications), End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centres and Other End Users) https://www.databridgemarketresearch.com/reports/global-liquid-biopsy-ma...
    Breast Cancer Liquid Biopsy Market , By Product (Consumables, Kits), Circulating Biomarkers (Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), ctRNA, Circulating Tumor Cells (CTCs), cfRNA, Others), End Users (Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories), Country https://www.databridgemarketresearch.com/reports/global-breast-cancer-li...
    Core Needle Biopsy Market , By Type (Full-Automated Core Needle Biopsy Device and Semi-Automated Core Needle Biopsy Device), Applications (Hospitals, Clinics and Others), Disease (Lung Cancer, Liver Cancer, Breast Cancer and Prostate Cancer), Range (14G- 18G, 18G), Distribution Channel (Direct Sales and Distributor), Country https://www.databridgemarketresearch.com/reports/global-core-needle-biop...
    Image-Guided Biopsy Market , By Technology (X- Ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country https://www.databridgemarketresearch.com/reports/global-image-guided-bio...
    Vacuum-Assisted Biopsy Market By Guiding Technique (Stereotactic Vacuum Assist Biopsy System and Image Guided Vacuum Assist Biopsy System), Type (9-12G, 12G), Applications (Hospitals, Academic and Research Institutes and Diagnostics and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Needle Biopsy Market , By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales), Country https://www.databridgemarketresearch.com/reports/global-needle-biopsy-ma...
    Biopsy Forceps Market , By Type (Rigid Biopsy Forceps, Flexible Biopsy Forceps), Product Type (Cupped Jaws Biopsy Forceps, Oval Ring Jaws Biopsy Forceps, Radial Jaw Biopsy Forceps, Others), Usability (Disposable Biopsy Forceps, Reusable Biopsy Forceps), Application (Laparoscopy, Hysterectomy, Hysteroscopy, Others), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-forceps-m...
    Biopsy Guns and Needles Market , By Product Type (Disposable, Reusable), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-guns-and-...